Evidence map›Paper›PMID 29690640›Full record

ArticleNanomaterials (Basel, Switzerland)2018

Non-Canonical Activation of the Epidermal Growth Factor Receptor by Carbon Nanoparticles.

Daniel Stöckmann, Tim Spannbrucker, Niloofar Ale-Agha, Philipp Jakobs, Christine Goy, Nadine Dyballa-Rukes, Tamara Hornstein, Alexander Kümper, Annette Kraegeloh, Judith Haendeler and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Daniel StöckmannIUF-Leibniz-Institut für Umweltmedizinische Forschung, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. daniel_stoeckmann@email.de.
Tim SpannbruckerIUF-Leibniz-Institut für Umweltmedizinische Forschung, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. Tim.Spannbrucker@IUF-duesseldorf.de.
Niloofar Ale-AghaIUF-Leibniz-Institut für Umweltmedizinische Forschung, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. Niloofar.ALE-AGHA@uni-duesseldorf.de.
Philipp JakobsIUF-Leibniz-Institut für Umweltmedizinische Forschung, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. Philipp.Jakobs@IUF-duesseldorf.de.
Christine GoyIUF-Leibniz-Institut für Umweltmedizinische Forschung, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. Christine.Goy@IUF-Duesseldorf.de.
Nadine Dyballa-RukesIUF-Leibniz-Institut für Umweltmedizinische Forschung, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. Nadine.Dyballa@uni-duesseldorf.de.
Tamara HornsteinIUF-Leibniz-Institut für Umweltmedizinische Forschung, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. Tamara.Hornstein@IUF-duesseldorf.de.
Alexander KümperINM-Leibniz-Institut für Neue Materialien, Campus D2 2, 66123 Saarbrücken, Germany. akuempi@web.de.
Annette KraegelohINM-Leibniz-Institut für Neue Materialien, Campus D2 2, 66123 Saarbrücken, Germany. Annette.Kraegeloh@leibniz-inm.de.
Judith HaendelerIUF-Leibniz-Institut für Umweltmedizinische Forschung, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. juhae001@uni-duesseldorf.de.ORCID 0000-0001-8507-4540
Klaus UnfriedIUF-Leibniz-Institut für Umweltmedizinische Forschung, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. klaus.unfried@uni-duesseldorf.de.
Leibniz Institute of Environmental Medicine · DELeibniz-Institute for New Materials · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidermal growth factor receptor (EGFR) is an abundant membrane protein, which is essential for regulating many cellular processes including cell proliferation. In our earlier studies, we observed an activation of the EGFR and subsequent signaling events after the exposure of epithelial cells to carbon nanoparticles. In the current study, we describe molecular mechanisms that allow for discriminating carbon nanoparticle-specific from ligand-dependent receptor activation. Caveolin-1 is a key player that co-localizes with the EGFR upon receptor activation by carbon nanoparticles. This specific process mediated by nanoparticle-induced reactive oxygen species and the accumulation of ceramides in the plasma membrane is not triggered when cells are exposed to non-nano carbon particles or the physiological ligand EGF. The role of caveolae formation was demonstrated by the induction of higher order structures of caveolin-1 and by the inhibition of caveolae formation. Using an in vivo model with genetically modified mice lacking caveolin-1, it was possible to demonstrate that carbon nanoparticles in vivo trigger EGFR downstream signaling cascades via caveolin-1. The identified molecular mechanisms are, therefore, of toxicological relevance for inhaled nanoparticles. However, nanoparticles that are intentionally applied to humans might cause side effects depending on this phenomenon.

Indexed as

airway epitheliumcaveolin-1lung inflammationprotein kinase Btyrosine kinase receptor

Identifiers

PMID29690640
PMCPMC5923597
OpenAlexW2800280817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.